Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-19-002774

President acquired 159,010 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
MAUNEY DAVID M MD President 2019-01-06 Grant or award +159,010 217,672 D
Derivatives
MAUNEY DAVID M MD President 2019-01-06 Grant or award · Employee Stock Option (right to buy) +250,733 250,733 D
Loading xslF345X03/doc4.xml…